Evidence has shown that expression of AQP4, the most abundant water channel in the central nervous system, is significantly higher in the brain of AD patients than in that of controls (Moftakhar et al., 2010), suggesting its potential role as a biomarker of cognition decline (Bergström et al., 2021). The gene discussed is AQP4; the disease is Alzheimer disease.